Current trends in the chemotherapy of brain tumors with special reference to glioblastomas.
D000470:Alkaloids / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001375:Azaguanine / Q000627:therapeutic use; D001807:Blood Vessel Prosthesis / Q000097:blood; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D001973:Bromodeoxyuridine / Q000627:therapeutic use; D002455:Cell Division; D002471:Cell Transformation, Neoplastic; D004195:Disease Models, Animal; D005472:Fluorouracil / Q000627:therapeutic use; D005909:Glioblastoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007269:Injections, Intra-Arterial; D007278:Injections, Spinal; D008466:Mechlorethamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009603:Nitroso Compounds / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D013997:Time Factors; D014508:Urea / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000470:Alkaloids; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D009603:Nitroso Compounds; D008466:Mechlorethamine; D014750:Vincristine; D014508:Urea; D013852:Thiotepa; D001973:Bromodeoxyuridine; D001375:Azaguanine; D005472:Fluorouracil; D008727:Methotrexate